← Back to headlines
Morgan Stanley Reiterates Overweight on Eli Lilly, Citing New Platform Potential
Morgan Stanley has reaffirmed its 'Overweight' rating on Eli Lilly (LLY), highlighting the substantial growth potential of the company's new platform. This positive outlook is based on anticipated future developments.
24 Mar, 11:27 — 24 Mar, 11:27
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Energy Secretary Confirms Diesel Cargo Arrival Amid Petronas Denial
just now
Philippine President Marcos Urges Unity, Warns Against Hoarding Amid Energy Crisis
just now
Marcos to decide on fuel excise tax cut or suspension by April 13
just now